44 results on '"Kanamori, Heiwa"'
Search Results
2. Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS: a KSGCT prospective study
3. Outcomes in patients with acute lymphoblastic leukemia who underwent second allogeneic hematopoietic cell transplantation for relapse after first transplantation
4. Compromised anti-tumor–immune features of myeloid cell components in chronic myeloid leukemia patients
5. A case series of patients treated with inotuzumab ozogamicin for acute lymphoblastic leukemia relapsed after allogeneic hematopoietic cell transplantation
6. Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy
7. Stopping tyrosine kinase inhibitors started after allogeneic HCT in patients with Philadelphia chromosome-positive leukemia
8. The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse
9. Health-related quality of life in peripheral blood stem cell donors and bone marrow donors: a prospective study in Japan
10. Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT collaborative study
11. Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemia
12. Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation
13. Salvage and bridging to allogeneic hematopoietic cell transplantation with ponatinib in patients with relapsed or refractory Philadelphia chromosome-positive leukemia
14. Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey
15. Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades
16. Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL
17. Impact of pretransplant leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR
18. Prospective observational study on the first 51 cases of peripheral blood stem cell transplantation from unrelated donors in Japan
19. Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia
20. D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations
21. Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia
22. Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling
23. A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey
24. Prognostic value of pretransplant serum C-reactive protein in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation
25. Outcomes of allogeneic hematopoietic cell transplantation in patients with biphenotypic acute leukemia
26. Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma
27. Clinical significance of the administration of cytarabine or thiotepa in addition to total body irradiation and cyclophosphamide for allogeneic hematopoietic cell transplantation in patients with acute leukemia
28. Thrombosis at ascending aorta following chemotherapy in a patient with acute myeloid leukemia
29. Prognostic factors in patients aged 50 years or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancy
30. Successful treatment with gemtuzumab ozogamicin and donor lymphocyte infusion for acute myeloid leukemia relapsing after allogeneic stem cell transplantation
31. Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
32. Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation
33. Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies
34. Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
35. Cerebral venous sinus thrombosis after allogeneic stem cell transplantation
36. The presence of mature granulocytes/monocytes derived from leukemic cells in MLL-associated leukemia
37. Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
38. Features of primary extranodal lymphoma in Kanagawa, a human T-cell leukemia virus type 1 nonendemic area in Japan
39. Acute Myelomonocytic Leukemia with Dysplastic Bone Marrow Eosinophils Showing t(5; 17)(q13;q11) and a Secondary Chromosomal Aberration, inv(16)(p13q22)
40. Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
41. Secondary Central Nervous System Lymphoma
42. Clinical Significance of Fragmented Red Cells after Allogeneic Bone Marrow Transplantation
43. Acute Lymphoblastic Leukemia with t(1;9;22)(q32;q34;Q11)
44. Posttransplantation Epstein-Barr Viral Meningitis in a Patient With Chronic Myelogenous Leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.